Age‐related cardiovascular disease in Down syndrome: A population‐based matched cohort study
Journal of Internal Medicine · 2025-06 · 297 (6) · 683-692
DOI: 10.1111/joim.20093 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Internal Medicine, online erschienen am 07.05.2025. Verfasst von Annie Pedersen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Down Syndrome, Cardiovascular Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Västra Götaland Regional Council, Karolinska Institutet Research Grants, Stockholm Regional County Council.
Abstract (Originalsprache)
Background
Life expectancy for individuals with Down syndrome (DS) has increased dramatically. To improve detection and prevention, the risk of age‐related cardiovascular disease in this population needs to be better defined.
Methods
We performed a population‐based matched cohort study. Through the National Patient Register (NPR) and/or the Medical Birth Register, we identified all individuals born in Sweden between 1946 and 2000 with a diagnosis of DS. Each individual with DS was matched to 50 comparators by sex, birth year, and county of birth. Data on ischemic and hemorrhagic stroke, acute myocardial infarction (AMI), and covariates indicating cardiovascular risk were retrieved from the NPR. Associations between DS and cardiovascular outcomes were estimated using Cox proportional hazards models. We also assessed the influence of cardiovascular risk factors.
Results
We included 5155 individuals with DS, of which 55% were male. The median age at the end of follow‐up was 35 in the DS population and 42 among the comparisons. DS was associated with increased risk of ischemic stroke (hazard ratios [HR] 4.41, 95% confidence intervals [CI] 3.53–5.52) and hemorrhagic stroke (HR 5.14, 95% CI 3.84–6.89). The overall risk of AMI was similar in DS and comparators but increased in young individuals with DS. The risk of ischemic stroke was elevated in individuals with DS with selected atherosclerotic (HR 12.67, 95% CI 7.04–22.78) as well as embolic (HR 10.35, 95% CI 6.69–16.01) risk factors, as compared to comparators without risk factors.
Conclusion
Individuals with DS were at increased risk of cardiovascular outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.
- Department of Clinical Genetics and Genomics, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Department of Radiology, Karolinska University Hospital, Stockholm, Sweden.
- Department of Molecular Medicine and Surgery, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
- Institute of Environmental Medicine, Karolinska Institutet, Unit of Epidemiology, Stockholm, Sweden.
- Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
ORCID-Profile: Annie Pedersen
Förderung
- Västra Götaland Regional Council
- Karolinska Institutet Research Grants
- Stockholm Regional County Council
- The Bertil Hållsten Research Foundation
- The Swedish Brain Foundation
- The Swedish Research Council
Zitieren
APA
Pedersen, A., Nordenvall, A. S., Tettamanti, G., & Nordgren, A. (2025). Age‐related cardiovascular disease in Down syndrome: A population‐based matched cohort study. Journal of Internal Medicine, 297(6), 683-692. https://doi.org/10.1111/joim.20093
Vancouver
Pedersen A, Nordenvall AS, Tettamanti G, Nordgren A. Age‐related cardiovascular disease in Down syndrome: A population‐based matched cohort study. Journal of Internal Medicine. 2025;297(6):683-692. doi:10.1111/joim.20093
BibTeX
@article{Pedersen2025,
author = {Pedersen, Annie and Nordenvall, Anna Skarin and Tettamanti, Giorgio and Nordgren, Ann},
title = {Age‐related cardiovascular disease in Down syndrome: A population‐based matched cohort study},
journal = {Journal of Internal Medicine},
year = {2025},
volume = {297},
number = {6},
pages = {683--692},
doi = {10.1111/joim.20093}
}
EUVIMED